| Literature DB >> 24555734 |
Karim Tararbit1, Nathalie Lelong, Lucile Houyel, Damien Bonnet, François Goffinet, Babak Khoshnood.
Abstract
BACKGROUND: Assisted reproductive techniques (ART) are associated with a higher risk of tetralogy of Fallot (TOF) and multiple pregnancies may be associated with a higher risk of congenital anomalies. We assessed the extent to which the association between ART and risk of TOF may be mediated by the higher risk of multiple pregnancies associated with ART.Entities:
Mesh:
Year: 2014 PMID: 24555734 PMCID: PMC3933480 DOI: 10.1186/1750-1172-9-27
Source DB: PubMed Journal: Orphanet J Rare Dis ISSN: 1750-1172 Impact factor: 4.123
Figure 1Decomposition of the total effect of ART on the risk of TOF into a direct effect and an indirect effect mediated through multiple pregnancies.
Associations between predictor variables and case/control status
| | ||||||
|---|---|---|---|---|---|---|
| | | | | | ||
| | Mean (SD) | 31.7 (5.6) | 30.4 (5.2) | <0.001 | ||
| | Median (p25-p75) | 31.5 (28 – 36) | 30 (27 – 34) | | ||
| | <20 | 3 | 0.8 | 59 | 1.4 | <0.001 |
| | 20 – 29 | 146 | 36.5 | 1,809 | 42.8 | |
| | 30 – 34 | 126 | 31.5 | 1,434 | 33.9 | |
| | 35 – 39 | 91 | 22.8 | 722 | 17.1 | |
| | ≥ 40 | 34 | 8.5 | 203 | 4.8 | |
| | | | | | | |
| | France | 200 | 50.4 | 2,412 | 57.9 | <0.001 |
| | North Africa | 72 | 18.1 | 433 | 10.4 | |
| | Subsaharan Africa | 39 | 9.8 | 550 | 13.2 | |
| | Other | 86 | 21.7 | 770 | 18.5 | |
| | | | | | | |
| | None | 113 | 30.9 | 1,083 | 26.3 | 0.096 |
| | Professional | 84 | 23.0 | 997 | 24.2 | |
| | Intermediate | 64 | 17.5 | 856 | 20.8 | |
| | Administrative/public service | 67 | 18.3 | 852 | 20.7 | |
| | Other | 38 | 10.4 | 330 | 8.0 | |
| | | | | | ||
| | Mean (SD) | 35.0 (6.6) | 33.9 (6.6) | 0.006 | ||
| | Median (p25-p75) | 34 (30 – 39) | 33 (29 – 38) | | ||
| | <20 | 1 | 0.3 | 5 | 0.1 | 0.014 |
| | 20 – 29 | 59 | 19.5 | 890 | 25.8 | |
| | 30 – 34 | 94 | 31.1 | 1,198 | 34.7 | |
| | 35 – 39 | 79 | 26.2 | 734 | 21.3 | |
| | ≥ 40 | 69 | 22.9 | 734 | 21.3 | |
| | | | | | | |
| | France | 179 | 49.2 | 2,325 | 58.6 | <0.001 |
| | North Africa | 66 | 18.1 | 416 | 10.5 | |
| | Subsaharan Africa | 38 | 10.4 | 529 | 13.3 | |
| | Other | 81 | 22.3 | 700 | 17.6 | |
| | | | | | | |
| | None | 24 | 7.6 | 281 | 7.4 | 0.014 |
| | Professional | 110 | 34.6 | 1,474 | 38.6 | |
| | Intermediate | 44 | 13.8 | 566 | 14.8 | |
| | Administrative/public service | 28 | 8.8 | 479 | 12.5 | |
| | Other | 112 | 35.2 | 1,020 | 26.7 | |
| | | | | | ||
| | Still-births | 18 | 4.5 | 7 | 0.2 | <0.001 |
| | Live-births | 269 | 66.6 | 4,231 | 99.6 | |
| | Pregnancy terminations | 117 | 29.0 | 12 | 0.3 | |
| None | 369 | 93.4 | 3,959 | 96.5 | 0.004 | |
| | IO$ only | 11 | 2.8 | 77 | 1.9 | |
| | IVF£ only | 10 | 2.5 | 55 | 1.3 | |
| IVF+ICSI¥ | 5 | 1.3 | 13 | 0.3 | ||
*n represents the number of cases or controls without missing data.
§% calculated with the number of cases or controls without missing data as a denominator.
$Inductors of ovulation.
£In vitro fertilization.
¥IVF with intracytoplasmic sperm injection.
Comparison of the study population characteristics according to exposure to ART (all methods combined)
| | | | | | ||
| Mean (SD) | 30.4 (5.2) | 33.0 (4.6) | <0.001 | |||
| Median (p25–p75) | 30 (27 – 34) | 33 (30 – 37) | | |||
| <20 | 61 | 1.4 | 0 | 0.0 | <0.001 | |
| 20 – 29 | 1,874 | 43.4 | 39 | 22.8 | ||
| 30 – 34 | 1,440 | 33.4 | 68 | 39.8 | ||
| 35 – 39 | 727 | 16.9 | 52 | 30.4 | ||
| ≥ 40 | 213 | 4.9 | 12 | 7.0 | ||
| | | | | | ||
| France | 2,416 | 56.4 | 124 | 72.9 | <0.001 | |
| North Africa | 484 | 11.3 | 11 | 6.5 | ||
| Subsaharan Africa | 573 | 13.4 | 9 | 5.3 | ||
| Other | 808 | 18.9 | 26 | 15.3 | ||
| | | | | | ||
| None | 1,134 | 27.1 | 24 | 14.2 | <0.001 | |
| Professional | 988 | 23.6 | 60 | 35.5 | ||
| Intermediate | 851 | 20.3 | 43 | 25.4 | ||
| Administrative/public service | 867 | 20.7 | 28 | 16.6 | ||
| Other | 346 | 8.3 | 14 | 8.3 | ||
| | | | | | ||
| Mean (SD) | 33.9 (6.6) | 35.0 (5.8) | 0.044 | |||
| Median (p25–p75) | 33 (29 – 38) | 34 (31 – 38) | ||||
| <20 | 6 | 0.2 | 0 | 0.0 | <0.001 | |
| 20 – 29 | 924 | 26.1 | 17 | 10.8 | ||
| 30 – 34 | 1,206 | 34.0 | 66 | 42.0 | ||
| 35 – 39 | 756 | 21.3 | 47 | 29.9 | ||
| ≥ 40 | 652 | 27.0 | 27 | 17.2 | ||
| | | | | | ||
| France | 2,327 | 57.1 | 118 | 71.5 | 0.002 | |
| North Africa | 463 | 11.4 | 11 | 6.7 | ||
| Subsaharan Africa | 550 | 13.5 | 11 | 6.7 | ||
| Other | 736 | 18.1 | 25 | 15.2 | ||
| | | | | | ||
| None | 291 | 7.5 | 6 | 3.7 | 0.023 | |
| Professional | 1,454 | 37.7 | 80 | 49.1 | ||
| Intermediate | 573 | 14.9 | 25 | 15.3 | ||
| Administrative/public service | 480 | 12.4 | 14 | 8.6 | ||
| Other | 1,060 | 27.5 | 38 | 23.3 | ||
| | | | | | ||
| Still-births | 22 | 0.5 | 3 | 1.8 | 0.099 | |
| Live-births | 4,183 | 96.3 | 163 | 95.3 | ||
| Pregnancy terminations | 123 | 2.8 | 5 | 2.9 | ||
| | Multiplicity | | | | | |
| Singletons | 2,908 | 97.0 | 94 | 71.8 | <0.001 | |
| Twins | 88 | 2.9 | 31 | 23.7 | ||
| Triplets | 3 | 0.1 | 6 | 4.6 | ||
§% calculated with the total of cases or controls without missing data as a denominator.
Decomposition of the total effect of ART on the odds of TOF into a direct effect and indirect effect mediated through multiple pregnancies
| None | 1.0 | ref. | 1.0 | ref. | 1.0 | ref. | 1.0 | ref. | 1.0 | ref. | 1.0 | ref. | |
| All methods combined | 1.9 | 1.2 – 3.1 | 2.6 | 1.5 – 4.5 | 1.7 | 1.0 – 2.8 | 2.1 | 1.2 – 3.7 | 1.1 | 1.0 – 1.4 | 1.2 | 1.0 – 1.5 | 20.9% |
| IO$ only | 1.4 | 0.7 – 2.9 | 2.1 | 1.0 – 4.7 | 1.3 | 0.7 – 2.6 | 1.8 | 0.9 – 3.9 | 1.1 | 1.0 – 1.2 | 1.2 | 1.0 – 1.3 | 19.1% |
| IVF£ only | 2.2 | 1.0 – 4.7 | 2.8 | 1.2 – 6.7 | 1.8 | 0.8 – 3.8 | 2.1 | 0.9 – 5.2 | 1.2 | 0.9 – 1.6 | 1.3 | 1.1 – 1.7 | 27.8% |
| IVF+ICSI¥ | 3.1 | 1.0 – 10.0 | 3.5 | 1.1 – 11.2 | 2.8 | 0.9 – 8.9 | 3.1 | 0.9 – 10.1 | 1.1 | 1.0 – 1.3 | 1.1 | 0.9 – 1.4 | 11.1% |
| IVF +/- ICSI | 2.4 | 1.3 – 4.6 | 3.0 | 1.6 – 5.8 | 2.1 | 1.0 – 4.3 | 2.4 | 1.2 – 4.6 | 1.2 | 0.9 – 1.5 | 1.3 | 1.0 – 1.6 | 22.3% |
*Odds ratios (OR) represent the odds of a birth (including live births, stillbirths and pregnancy terminations) with TOF (cases) relative to the odds of a birth with one of the malformed controls (club-foot, angioma, skin abnormality, polydactyly, syndactyly, and congenital hip dislocation).
§Adjustment was made for maternal age, occupation, geographic origin, paternal age and year of birth.
$Inductors of ovulation.
£In vitro fertilization.
¥IVF with intracytoplasmic sperm injection.
Decomposition of the total effect of ART on the odds of TOF without associated chromosomal anomalies into a direct effect and indirect effect mediated through multiple pregnancies
| None | 1.0 | ref. | 1.0 | ref. | 1.0 | ref. | 1.0 | ref. | 1.0 | ref. | 1.0 | ref. | |
| All methods combined | 2.3 | 1.5 – 3.5 | 3.2 | 2.1 – 4.7 | 1.9 | 1.2 – 3.0 | 2.5 | 1.6 – 3.8 | 1.2 | 1.0 – 1.4 | 1.3 | 1.1 – 1.5 | 21.5% |
| IO$ only | 1.7 | 0.9 – 3.1 | 2.6 | 1.3 – 5.0 | 1.5 | 0.8 – 2.7 | 2.2 | 1.2 – 4.0 | 1.1 | 1.0 – 1.3 | 1.2 | 1.0 – 1.4 | 18.9% |
| IVF£ only | 2.5 | 1.1 – 6.1 | 3.4 | 1.6 – 7.2 | 1.9 | 0.8 – 5.0 | 2.4 | 1.2 – 4.8 | 1.3 | 1.0 – 1.7 | 1.4 | 1.0 – 2.0 | 29.7% |
| IVF+ICSI¥ | 4.0 | 1.2 – 13.1 | 4.4 | 1.2 – 15.9 | 3.5 | 1.1 – 11.5 | 3.7 | 1.0 – 13.8 | 1.1 | 0.9 – 1.4 | 1.2 | 0.9 – 1.5 | 11.7% |
| IVF +/- ICSI | 2.9 | 1.6 – 5.4 | 3.7 | 2.0 – 7.0 | 2.3 | 1.2 – 4.6 | 2.7 | 1.5 – 4.9 | 1.2 | 1.0 – 1.5 | 1.4 | 1.0 – 1.9 | 23.6% |
*Odds ratios (OR) represent the odds of a birth (including live births. stillbirths and pregnancy terminations) with TOF (cases) relative to the odds of a birth with one of the malformed controls (club-foot, angioma, skin abnormality, polydactyly, syndactyly, and congenital hip dislocation).
§Adjustment was made for maternal age, occupation, geographic origin, paternal age and year of birth.
$Inductors of ovulation.
£In vitro fertilization.
¥IVF with intracytoplasmic sperm injection.